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INTRODUCTION {#ppul23570-sec-0002}
============

Respiratory syncytial virus (RSV) is a seasonal disease and causes an enormous burden on health systems across the world. RSV disease manifestations in children range from mild upper respiratory tract infection to severe respiratory infection including pneumonia or bronchiolitis which can lead to hospitalization and serious complications such as respiratory failure.[1](#ppul23570-bib-0001){ref-type="ref"}, [2](#ppul23570-bib-0002){ref-type="ref"}, [3](#ppul23570-bib-0003){ref-type="ref"} Certain high‐risk groups, including premature infants; infants with underlying medical conditions such as chronic lung disease of prematurity (CLDP) or bronchopulmonary dysplasia (BPD); hemodynamically significant congenital heart disease (hsCHD); immunocompromised conditions; or severe neuromuscular disease, are prone to serious disease due to RSV with higher morbidity and mortality rates than those without these conditions.[4](#ppul23570-bib-0004){ref-type="ref"}, [5](#ppul23570-bib-0005){ref-type="ref"}

In addition to severe acute disease, evidence also suggests that children who had severe RSV infection early in life are more likely to develop subsequent wheezing during early childhood[6](#ppul23570-bib-0006){ref-type="ref"} and hyperreactive airways and asthma later in life.[7](#ppul23570-bib-0007){ref-type="ref"}

The reported incidence and mortality of RSV acute respiratory infection (ARI) is highly variable by geographic location, case ascertainment, populations under surveillance, and the diagnostic method used to identify RSV. In 2005, Nair et al.[3](#ppul23570-bib-0003){ref-type="ref"} estimated that there were 33.8 million new episodes of RSV‐associated acute lower respiratory infections (ALRIs) worldwide in children \<5 years of age, including 3.4 million episodes of severe RSV‐ALRI requiring hospitalization with 66,000--190,000 deaths from RSV‐associated ALRI in 2005.

The aim of this study was to review the global burden of RSV disease in children and update current published data. In addition we focused on prematurity as a risk factor for RSV disease as premature infants have been reported to be disproportionately affected by RSV, and at higher risk for worse outcomes due to interrupted lung development[8](#ppul23570-bib-0008){ref-type="ref"} and reduced maternally transmitted antibodies.[9](#ppul23570-bib-0009){ref-type="ref"}

METHODS {#ppul23570-sec-0003}
=======

Search Strategy and Screening Criteria {#ppul23570-sec-0004}
--------------------------------------

This study was a systematic literature review and meta‐analysis of published scientific evidence on the burden of severe ARI due to RSV (RSV‐ARI). A technology‐assisted search and screening was conducted at the direction of the authors by Doctor Evidence (Santa Monica, CA). Professional medical librarians, in collaboration with the authors, developed search strategies for Medline search (via PubMed) and Embase search (via Ovid; e‐Appendix). The search was performed in February 2015, and was limited to published primary literature in the English language, human subjects, and children (birth to 5 years). The search terms used are detailed in the e‐Appendix. The authors (CW, CP) reviewed all potentially relevant references independently and selected relevant publications for data analysis.

The study inclusion criteria for the systematic review were studies: (1) reporting the incidence of first episode of community acquired, medically attended, severe RSV‐ARI in children ≤5 years of age not receiving RSV immunoprophylaxis with palivizumab. Cases of severe ARI included hospitalized ARI or hospitalized lower or acute lower respiratory infection, pneumonia, and bronchiolitis. Medically attended was defined as either hospitalized (on the basis of the assessment of the admitting physician) for RSV infection or outpatient visit (emergency department, urgent care, or pediatric clinic) with RSV‐ARI; (2) reporting data on laboratory confirmed diagnosis of RSV through enzyme‐linked immunosorbent assay, polymerase chain reaction (PCR; Multiplex), immunofluorescence (IF), culture, direct fluorescent antibody test (DFA), or by relevant International Classification of Diseases‐9 (ICD‐9) diagnosis codes; (3) research conducted from the year 2000 to the present date. Studies from pre‐ and post‐2000 periods were included only if data were reported separately for the post‐2000 period. As the molecular assays such as multiplex PCR, RT‐PCR for respiratory virus detection did not become available for research/commercial use until the early 2000 s the date limit of 15 years (2000--2015) was used to capture studies that used molecular essays rather than older diagnostic methods with lower sensitivity and specificity.

Exclusion criteria for the systematic review were studies: (1) reporting data for children prophylaxed with palivizumab or other prevention strategies for RSV infection; (2) reporting data on treatment of RSV infection; (3) reporting data in special populations including children with cystic fibrosis or immunocompromised conditions; (4) reporting data for nosocomial acquired RSV‐ARI; (5) reporting preliminary results such as an abstract or poster displayed at a professional meeting, single case reports, letters/editorials, and commentaries.

Statistical Analysis {#ppul23570-sec-0005}
--------------------

The two main outcomes were (1) hospitalization for severe RSV‐ARI, measured as hospitalization rates per 1,000 children per year as defined above; and (2) death among the children with severe RSV‐ARI, measured as case fatalities. The data for these primary outcomes were synthesized separately by chronological and gestational age categories (\<6 months, \<1 year, \<2 years, 2--5 years, and \<5 years, \<1 year and preterm \[≤36 weeks gestational age\]). When sufficient data were available (i.e., a minimum of four studies), we also conducted analyses by geographic region. The delineation of regions was based on an attempt to define areas by the likeness of their inherent characteristics (i.e., population, economy, and physical environment). Subsequently, five regions were defined, which included Africa, Asia, Australia/Europe/United States, Gulf/Middle East, and Latin America.

The study data were synthesized by means of a random effect meta‐analysis using a Bayesian framework. Models with a normal likelihood for the (log‐transformed) hospitalization rate data and with a binomial likelihood for case fatality data were used. Prior distributions were chosen to be vague; a normal distribution with mean 0 and variance 10^3^ for the (log) summary estimate (hospitalization rate or odds of fatality) and a uniform distribution of range 0--2 for the heterogeneity parameter were employed. Summary statistics (median and 95% credible interval \[CrI\]) are provided for each analysis, with a minimum of four studies. With a Bayesian approach, the results produce a point estimate and CrI, which arise from the posterior probability distribution. Analyses were performed using R (version 3.0.2) and Bayesian software WinBUGS (version 1.4.3; MRC Biostatistics Unit, Cambridge, UK).

RESULTS {#ppul23570-sec-0006}
=======

In the first pass of the review strategy, 5,274 potentially relevant references were retrieved (3,628 from Medline and 1,646 from Embase). Of those references, 4,685 were rejected in the first pass (using title/abstract screening), the majority for wrong/divergent outcomes (N = 1,683) or not being a clinical study (n = 1,782). The remaining 589 potentially acceptable references were reviewed using a full‐text screening and 293 references were further rejected for out‐of‐target variables: populations (n = 106), outcomes (n = 169), study design (n = 15), and other reasons (n = 3). From the 296 remaining studies, the majority of further rejections were due to insufficient incidence/mortality data (n = 126) and reporting of pre‐2000 data (n = 67). In total, 55 studies were included in the report: 34 reported on the incidence of hospitalization for severe RSV‐ARI and 37 reported on death among the children with severe RSV‐ARI (Fig. [1](#ppul23570-fig-0001){ref-type="fig"}).

![PRISMA flow diagram: RSV incidence and case fatality analysis. CFR, case fatality ratio; RSV, respiratory syncytial virus; SE, standard error. \*Insufficient number of studies for age group analysis.](PPUL-52-556-g001){#ppul23570-fig-0001}

Incidence of RSV‐Associated Severe ARI Hospitalization {#ppul23570-sec-0007}
------------------------------------------------------

Thirty‐four studies[10](#ppul23570-bib-0010){ref-type="ref"}, [11](#ppul23570-bib-0011){ref-type="ref"}, [12](#ppul23570-bib-0012){ref-type="ref"}, [13](#ppul23570-bib-0013){ref-type="ref"}, [14](#ppul23570-bib-0014){ref-type="ref"}, [15](#ppul23570-bib-0015){ref-type="ref"}, [16](#ppul23570-bib-0016){ref-type="ref"}, [17](#ppul23570-bib-0017){ref-type="ref"}, [18](#ppul23570-bib-0018){ref-type="ref"}, [19](#ppul23570-bib-0019){ref-type="ref"}, [20](#ppul23570-bib-0020){ref-type="ref"}, [21](#ppul23570-bib-0021){ref-type="ref"}, [22](#ppul23570-bib-0022){ref-type="ref"}, [23](#ppul23570-bib-0023){ref-type="ref"}, [24](#ppul23570-bib-0024){ref-type="ref"}, [25](#ppul23570-bib-0025){ref-type="ref"}, [26](#ppul23570-bib-0026){ref-type="ref"}, [27](#ppul23570-bib-0027){ref-type="ref"}, [28](#ppul23570-bib-0028){ref-type="ref"}, [29](#ppul23570-bib-0029){ref-type="ref"}, [30](#ppul23570-bib-0030){ref-type="ref"}, [31](#ppul23570-bib-0031){ref-type="ref"}, [32](#ppul23570-bib-0032){ref-type="ref"}, [33](#ppul23570-bib-0033){ref-type="ref"}, [34](#ppul23570-bib-0034){ref-type="ref"}, [35](#ppul23570-bib-0035){ref-type="ref"}, [36](#ppul23570-bib-0036){ref-type="ref"}, [37](#ppul23570-bib-0037){ref-type="ref"}, [38](#ppul23570-bib-0038){ref-type="ref"}, [39](#ppul23570-bib-0039){ref-type="ref"}, [40](#ppul23570-bib-0040){ref-type="ref"}, [41](#ppul23570-bib-0041){ref-type="ref"} from 26 countries that were published between 2002 and 2014, with RSV‐associated ARI hospitalization rates for community‐acquired, medically attended, laboratory‐confirmed severe RSV‐ARI in children \<5 years of age, were included in the incidence analysis. The incidence estimates of RSV‐associated ARI hospitalization (per 1,000 children per year) were stratified according to age and region (Table [1](#ppul23570-tbl-0001){ref-type="table-wrap"}). The regional estimates for each age group were constructed from separate estimates at the study level, when four or more study‐level estimates were available. Global estimates for each age group were constructed from all of the estimates at the study level. The studies estimated incidence for RSV‐associated ARI hospitalization by utilizing a passive case ascertainment (patients presented to the health facility with ARI), active case ascertainment (by proactive means of disease monitoring via surveys and home visits), or a combination of both. Most studies (n = 44) used passive hospital or clinic‐based case ascertainment, five studies used active community‐based case ascertainment, and six studies used a combination approach. In the majority of included studies, RSV was confirmed using standard RSV detection methods (rapid antigen, DFA test, multiplex reverse transcription PCR, reverse transcriptase PCR, immunofluorescence, or other assays). In six studies, RSV‐specific ICD‐9 codes were used as a basis for case identification. Table [2](#ppul23570-tbl-0002){ref-type="table-wrap"} provides a summary of characteristics for studies included in the analysis.

###### 

Estimates of Incidence of RSV‐ARI Hospitalization for Children \<6 Months to 5 Years of Age (Per 1,000 Children Per Year)

  Age                                                                                                   Study                                                                                         Incidence rate (95% CI)   Meta‐analysis of incidence rates (95% CI)
  ----------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------- ------------------------- -------------------------------------------
  Africa                                                                                                                                                                                                                        
  \<6 months                                                                                                                                                                                                                    
  \<1 year                                                                                              Kenya[28](#ppul23570-bib-0028){ref-type="ref"}                                                11.07 (10.12--12.11)      n/a
  South Africa[25](#ppul23570-bib-0025){ref-type="ref"}                                                 32.00 (29.55--34.65)                                                                                                    
  South Africa[33](#ppul23570-bib-0033){ref-type="ref"}                                                 15.00 (9.59--23.45)                                                                                                     
  \<2 years                                                                                                                                                                                                                     
  2--5 years                                                                                            South Africa[25](#ppul23570-bib-0025){ref-type="ref"}                                         4.00 (3.10--5.16)         n/a
  \<5 years                                                                                             Kenya[28](#ppul23570-bib-0028){ref-type="ref"}                                                2.93 (2.50--3.43)         4.57 (1.25--16.19)
  Mozambique[29](#ppul23570-bib-0029){ref-type="ref"}                                                   1.40 (0.97--2.03)                                                                                                       
  South Africa[25](#ppul23570-bib-0025){ref-type="ref"}                                                 11.20 (10.61--11.82)                                                                                                    
  South Africa[33](#ppul23570-bib-0033){ref-type="ref"}                                                 9.00 (7.53--10.76)                                                                                                      
  \<1year preterm                                                                                                                                                                                                               
  Asia                                                                                                                                                                                                                          
  \<6 months                                                                                            Hong Kong[15](#ppul23570-bib-0015){ref-type="ref"}                                            31.12 (27.80--34.83)      n/a
  India[12](#ppul23570-bib-0012){ref-type="ref"}                                                        13.68 (9.06--20.65)                                                                                                     
  Thailand[26](#ppul23570-bib-0026){ref-type="ref"}                                                     11.95 (9.78--14.60)                                                                                                     
  \<1 year                                                                                              Hong Kong[15](#ppul23570-bib-0015){ref-type="ref"}                                            23.34 (20.49--26.59)      16.40 (7.79--34.08)
  India[13](#ppul23570-bib-0013){ref-type="ref"}                                                        14.00 (4.22--46.23)                                                                                                     
  India[12](#ppul23570-bib-0012){ref-type="ref"}                                                        7.85 (5.55--11.10)                                                                                                      
  Thailand[20](#ppul23570-bib-0020){ref-type="ref"}                                                     10.87 (9.82--12.03)                                                                                                     
  Thailand[26](#ppul23570-bib-0026){ref-type="ref"}                                                     15.43 (13.73--17.34)                                                                                                    
  Vietnam[41](#ppul23570-bib-0041){ref-type="ref"}                                                      40.90 (33.34--50.18)                                                                                                    
  \<2 years                                                                                             Indonesia[17](#ppul23570-bib-0017){ref-type="ref"}                                            10.00 (9.25--10.82)       n/a
  Vietnam[40](#ppul23570-bib-0040){ref-type="ref"}                                                      23.43 (21.11--26.00)                                                                                                    
  2--5 years                                                                                            Hong Kong[15](#ppul23570-bib-0015){ref-type="ref"}                                            3.39 (2.39--4.81)         n/a
  Thailand[26](#ppul23570-bib-0026){ref-type="ref"}                                                     6.38 (5.77--7.06)                                                                                                       
  \<5 years                                                                                             Bangladesh[27](#ppul23570-bib-0027){ref-type="ref"}                                           4.11 (2.64--6.40)         4.95 (2.69--8.95)
  India[12](#ppul23570-bib-0012){ref-type="ref"}                                                        2.63 (2.01--3.44)                                                                                                       
  Taiwan[14](#ppul23570-bib-0014){ref-type="ref"}                                                       2.32 (2.24--2.41)                                                                                                       
  Thailand[20](#ppul23570-bib-0020){ref-type="ref"}                                                     5.07 (4.61--5.58)                                                                                                       
  Thailand[26](#ppul23570-bib-0026){ref-type="ref"}                                                     9.81 (9.21--10.45)                                                                                                      
  Thailand[37](#ppul23570-bib-0037){ref-type="ref"}                                                     5.80 (4.33--7.77)                                                                                                       
  Vietnam[40](#ppul23570-bib-0040){ref-type="ref"}                                                      9.59 (8.71--10.56)                                                                                                      
  \<1 year preterm                                                                                      Korea[32](#ppul23570-bib-0032){ref-type="ref"}, [^\*^](#ppul23570-note-0002){ref-type="fn"}   45.29 (32.81--62.50)      n/a
  Australia, Europe, United States                                                                                                                                                                                              
  \<6 months                                                                                            United States[22](#ppul23570-bib-0022){ref-type="ref"}                                        41.90 (32.69--53.71)      n/a
  \<1 year                                                                                              Denmark[38](#ppul23570-bib-0038){ref-type="ref"}                                              50.69 (28.07--91.54)      23.69 (15.08--39.98)
  Germany[39](#ppul23570-bib-0039){ref-type="ref"}                                                      27.21 (21.76--34.02)                                                                                                    
  United States[22](#ppul23570-bib-0022){ref-type="ref"}                                                27.40 (21.51--34.90)                                                                                                    
  United States[31](#ppul23570-bib-0031){ref-type="ref"}                                                17.38 (17.09--17.68)                                                                                                    
  United States[36](#ppul23570-bib-0036){ref-type="ref"}                                                26.00 (20.59--32.84)                                                                                                    
  United States[35](#ppul23570-bib-0035){ref-type="ref"}                                                14.40 (14.10--14.70)                                                                                                    
  \<2 years                                                                                             Australia[16](#ppul23570-bib-0016){ref-type="ref"}                                            20.40 (17.51--23.76)      n/a
  Germany[39](#ppul23570-bib-0039){ref-type="ref"}                                                      15.90 (12.93--19.55)                                                                                                    
  United States[23](#ppul23570-bib-0023){ref-type="ref"}                                                23.00 (22.70--23.30)                                                                                                    
  2--5 years                                                                                            Germany[39](#ppul23570-bib-0039){ref-type="ref"}                                              1.81 (1.07--3.06)         n/a
  United States[39](#ppul23570-bib-0039){ref-type="ref"}                                                0.80 (0.62--1.03)                                                                                                       
  \<5 years                                                                                             United States[31](#ppul23570-bib-0031){ref-type="ref"}                                        4.53 (4.46--4.60)         n/a
  United States[39](#ppul23570-bib-0039){ref-type="ref"}                                                6.70 (5.42--8.28)                                                                                                       
  \<1 year preterm                                                                                      France[68](#ppul23570-bib-0068){ref-type="ref"}, [^†^](#ppul23570-note-0003){ref-type="fn"}   64.26 (39.37--104.89)     n/a
  Netherlands[69](#ppul23570-bib-0069){ref-type="ref"}, [^‡^](#ppul23570-note-0004){ref-type="fn"}      39.42 (28.69--54.17)                                                                                                    
  United Kingdom[18](#ppul23570-bib-0018){ref-type="ref"}, [^§^](#ppul23570-note-0005){ref-type="fn"}   51.80 (35.99--74.53)                                                                                                    
  Latin America                                                                                                                                                                                                                 
  \<6 months                                                                                            Argentina[19](#ppul23570-bib-0019){ref-type="ref"}                                            31.00 (28.60--33.60)      n/a
  Guatemala[24](#ppul23570-bib-0024){ref-type="ref"}                                                    9.50 (8.61--10.48)                                                                                                      
  \<1 year                                                                                              Argentina[19](#ppul23570-bib-0019){ref-type="ref"}                                            23.70 (22.31--25.18)      n/a
  \<2 years                                                                                             Argentina[19](#ppul23570-bib-0019){ref-type="ref"}                                            14.10 (13.13--15.14)      
  Chile[11](#ppul23570-bib-0011){ref-type="ref"}                                                        5.54 (4.70--6.52)                                                                                                       
  2--5 years                                                                                            Guatemala[24](#ppul23570-bib-0024){ref-type="ref"}                                            0.20 (0.14--0.26)         n/a
  \<5 years                                                                                             Guatemala[24](#ppul23570-bib-0024){ref-type="ref"}                                            1.80 (1.68--1.93)         n/a
  \<1 year preterm                                                                                      Brazil[10](#ppul23570-bib-0010){ref-type="ref"}, [^§^](#ppul23570-note-0005){ref-type="fn"}   99.01 (69.22--141.61)     n/a
  Peru[30](#ppul23570-bib-0030){ref-type="ref"}, [^‖^](#ppul23570-note-0006){ref-type="fn"}             116.20 (83.81--161.10)                                                                                                  
  Gulf/Middle East                                                                                                                                                                                                              
  \<6 months                                                                                                                                                                                                                    
  \<1 year                                                                                              Egypt[34](#ppul23570-bib-0034){ref-type="ref"}                                                17.45 (16.24--18.75)      n/a
  Turkey[21](#ppul23570-bib-0021){ref-type="ref"}                                                       13.40 (11.74--15.29)                                                                                                    
  \<2 years                                                                                             Turkey[21](#ppul23570-bib-0021){ref-type="ref"}                                               7.70 (6.81--8.71)         n/a
  2--5 years                                                                                                                                                                                                                    
  \<5 years                                                                                             Egypt[34](#ppul23570-bib-0034){ref-type="ref"}                                                2.42 (2.27--2.59)         n/a
  \<1 year preterm                                                                                                                                                                                                              
  Global                                                                                                                                                                                                                        
  \<6 months                                                                                                                                                                                                                    20.01 (9.65--41.31)
  \<1 year                                                                                                                                                                                                                      19.19 (15.04--24.48)
  \<2 years                                                                                                                                                                                                                     13.42 (8.20--21.89)
  2--5 years                                                                                                                                                                                                                    1.71 (0.53--5.46)
  \<5 years                                                                                                                                                                                                                     4.37 (2.98--6.42)
  \<1 year preterm                                                                                                                                                                                                              63.85 (37.52--109.7)

ARI, acute respiratory infection; CI, confidence interval; n/a, not analyzed; RSV, respiratory syncytial virus.

Gestational age: \<35 weeks.

Gestational age: \<33 weeks.

Gestational age: 32--36 weeks.

Gestational age: \<36 weeks.

Gestational age: \<37 weeks.

© 2016 Wiley Periodicals, Inc.

###### 

Study Characteristics

  Author, year                                                               Country          Study period analyzed                                                                Study population (description)                                                                                                     Study population (enrolled)   Surveillance method   RSV diagnosis method
  -------------------------------------------------------------------------- ---------------- ------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------- ----------------------------- --------------------- -------------------------------------------
  Africa                                                                                                                                                                                                                                                                                                                                                                  
  Robertson et al., 2004[33](#ppul23570-bib-0033){ref-type="ref"}            South Africa     April 2000--March 2001                                                               Children \<5 years old with ARI                                                                                                    NR                            Passive               ELISA
  Nokes et al., 2009[28](#ppul23570-bib-0028){ref-type="ref"}                Kenya            January 2002--December 2007                                                          Children \<5 years old with severe or very severe pneumonia                                                                        6,026                         Passive               DFA
  Jroundi et al., 2014[49](#ppul23570-bib-0049){ref-type="ref"}              Morocco          November 2010--December 2011                                                         Children 2--59 months old admitted with respiratory symptomatology and WHO definition of clinical severe pneumonia                 700                           Passive               Multiplex RT‐PCR
  O\'Callaghan‐Gordo et al., 2011[29](#ppul23570-bib-0029){ref-type="ref"}   Mozambique       September 2006--September 2007                                                       Children \<5 years old admitted with clinical severe pneumonia                                                                     807                           Passive               Multiplex RT‐PCR
  Cohen et al., 2015[46](#ppul23570-bib-0046){ref-type="ref"}                South Africa     February 2009--December 2012                                                         Children \<5 years old admitted with physician‐diagnosed ARI                                                                       8,723                         Passive               Multiplex RT‐PCR
  Madhi et al., 2003[52](#ppul23570-bib-0052){ref-type="ref"}                South Africa     April 2000--September 2001                                                           Children \<24 months old diagnosed with ARI                                                                                        220                           Passive               ELISA
  Moyes et al., 2013[25](#ppul23570-bib-0025){ref-type="ref"}                South Africa     January 2010--December 2011                                                          Children \<5 years old admitted with physician‐diagnosed neonatal sepsis or ARI                                                    4,489                         Passive               Multiplex RT‐PCR
  Venter et al., 2011[60](#ppul23570-bib-0060){ref-type="ref"}               South Africa     2006--2007                                                                           Children \<5 years old                                                                                                             1,637                         Passive               DFA, ELISA, Multiplex RT‐PCR
  Asia                                                                                                                                                                                                                                                                                                                                                                    
  Nasreen et al., 2014[27](#ppul23570-bib-0027){ref-type="ref"}              Bangladesh       June 2010--October 2010                                                              Children \<5 years old with severe ARI                                                                                             12,850                        Active and passive    Multiplex RT‐PCR
  Leung et al., 2014[51](#ppul23570-bib-0051){ref-type="ref"}                China            January 2009--June 2011                                                              Children with severe RSV requiring PICU admission                                                                                  4,912                         Passive               DFA and/or viral culture
  Zhang et al., 2014[61](#ppul23570-bib-0061){ref-type="ref"}                China            January 2005--December 2009                                                          Children admitted with RSV infection                                                                                               959                           Passive               DFA
  Zhang et al., 2014[62](#ppul23570-bib-0062){ref-type="ref"}                China            March 2011--February 2012                                                            Infants \<1 year old with RSV‐associated ARI                                                                                       913                           Passive               DFA
  Chiu et al., 2010[15](#ppul23570-bib-0015){ref-type="ref"}                 Hong Kong        October 2003--September 2006                                                         Children \<18 years old admitted with febrile ARI                                                                                  1,031                         Passive               DFA
  Broor et al., 2007[13](#ppul23570-bib-0013){ref-type="ref"}                India            October 2001--December 2004                                                          Newborns followed until 3 years                                                                                                    281                           Active                DFA
  Broor et al., 2014[12](#ppul23570-bib-0012){ref-type="ref"}                India            August 2009--July 2011                                                               Children \<5 years old admitted with an acute medical illness                                                                      245                           Passive               RT‐PCR
  Hemalatha et al., 2010[48](#ppul23570-bib-0048){ref-type="ref"}            India            2007--2008                                                                           Children with respiratory infection (pneumonia, bronchiolitis, or upper respiratory infection)                                     126                           Passive               ELISA
  Djelantik et al., 2003[17](#ppul23570-bib-0017){ref-type="ref"}            Indonesia        2000--2001                                                                           Children \<2 years old admitted with severe ARI                                                                                    3,777                         Passive               Rapid EIA
  Park et al., 2012[32](#ppul23570-bib-0032){ref-type="ref"}                 Korea            April 2007--September 2009                                                           Newborn infants born \<35 weeks gestational age and discharged from NICU                                                           1,111                         Active                Antigen test, culture
  Cho et al., 2013[45](#ppul23570-bib-0045){ref-type="ref"}                  South Korea      January 2009--May 2010                                                               Neonates \<1 month old admitted to the NICU because of ARI                                                                         108                           Passive               Multiplex RT‐PCR
  Chen et al., 2005[44](#ppul23570-bib-0044){ref-type="ref"}                 Taiwan           January 2001--December 2003                                                          Children \<5 years old admitted with ARI                                                                                           650                           Passive               Rapid EIA, culture
  Chi et al., 2011[14](#ppul23570-bib-0014){ref-type="ref"}                  Taiwan           2004--2007                                                                           Children with RSV‐associated hospitalization                                                                                       11,081                        Passive               ICD‐9 codes
  Fry et al., 2010[20](#ppul23570-bib-0020){ref-type="ref"}                  Thailand         September 2003--December 2007                                                        Hospitalized patients with RSV infections (including pneumonia) from all age groups in a population‐based surveillance             11,097                        Passive               RT‐PCR
  Naorat et al., 2013[26](#ppul23570-bib-0026){ref-type="ref"}               Thailand         January 2008--December 2011                                                          Children admitted with ARI                                                                                                         13,982                        Passive               RT‐PCR
  Suntarattiwong et al., 2011[59](#ppul23570-bib-0059){ref-type="ref"}       Thailand         December 2007--August 2009                                                           Children 1--12 months old admitted with ARI                                                                                        349                           Passive               RT‐PCR
  Suwanjutha et al., 2002[37](#ppul23570-bib-0037){ref-type="ref"}           Thailand         November 1998--February 2001                                                         Children \<5 years old in the community                                                                                            7,890                         Passive               IF
  Yoshida et al., 2010[41](#ppul23570-bib-0041){ref-type="ref"}              Vietnam          February 2007--March 2008                                                            Hospitalized children with ARI                                                                                                     958                           Passive               Multiplex RT‐PCR
  Yoshida et al., 2013[40](#ppul23570-bib-0040){ref-type="ref"}              Vietnam          April 2007--March 2010                                                               Children 1--60 months old with ARI in the community                                                                                1,786                         Passive               Multiplex RT‐PCR
  Australia, Europe, United States                                                                                                                                                                                                                                                                                                                                        
  Dede et al., 2010[16](#ppul23570-bib-0016){ref-type="ref"}                 Australia        January 2000--December 2004                                                          Children \<2 years old admitted with RSV                                                                                           173                           Passive               DFA
  von Linstow et al., 2008[38](#ppul23570-bib-0038){ref-type="ref"}          Denmark          May 2004--May 2005                                                                   Healthy infants in the community                                                                                                   242                           Active                ELISA, RT‐PCR
  Gouyon et al., 2013[68](#ppul23570-bib-0068){ref-type="ref"}               France           September 2008--April 2009                                                           Infants admitted for bronchiolitis                                                                                                 554                           Active and passive    IF
  Weigl et al., 2002[39](#ppul23570-bib-0039){ref-type="ref"}                Germany          July 1994--June 2001                                                                 Newborn to 16‐year‐old children admitted with ARI                                                                                  2,367                         Passive               Multiplex RT‐PCR
  Gijtenbeek et al., 2014[69](#ppul23570-bib-0069){ref-type="ref"}           Netherlands      2002--2003                                                                           Children born moderately preterm, full‐term, or early preterm                                                                      2,099                         Passive               Antigen detection, cell culture
  Stollar et al., 2014[58](#ppul23570-bib-0058){ref-type="ref"}              Switzerland      2010--2012                                                                           Children \<1 year old admitted to the ED with acute bronchiolitis                                                                  202                           Passive               ELISA, RT‐PCR
  Drysdale et al., 2013[18](#ppul23570-bib-0018){ref-type="ref"}             United Kingdom   2008--2009                                                                           Infants born at \<36 weeks gestational age                                                                                         177                           Active                RT‐PCR
  Byington et al., 2015[43](#ppul23570-bib-0043){ref-type="ref"}             United States    2000--2011                                                                           Children \<2 years old hospitalized with ICD‐9‐CM diagnosis codes for RSV pneumonia, RSV bronchiolitis, and bronchiolitis, other   NR                            Passive               ICD‐9 codes
  Holman et al., 2004[22](#ppul23570-bib-0022){ref-type="ref"}               United States    2000--2001                                                                           Infants hospitalized with RSV                                                                                                      7,796                         Passive               ICD‐9 codes
  Light et al., 2008[23](#ppul23570-bib-0023){ref-type="ref"}                United States    2001--2004                                                                           Children \<24 months old hospitalized because of RSV‐ARI                                                                           \>23,000                      Passive               ICD‐9 codes, antigen detection or culture
  Paramore et al., 2004[31](#ppul23570-bib-0031){ref-type="ref"}             United States    2000                                                                                 Children with RSV‐related discharge diagnosis                                                                                      NR                            Passive               ICD‐9 codes
  Sangaré et al., 2006[35](#ppul23570-bib-0035){ref-type="ref"}              United States    2000--2003                                                                           Infants with RSV‐coded hospitalizations                                                                                            45,330                        Passive               ICD‐9 codes
  Stockman et al., 2012[36](#ppul23570-bib-0036){ref-type="ref"}             United States    1997--2006                                                                           Children \<5 years old with ARI and RSV‐related discharge diagnoses                                                                NR                            Passive               ICD‐9 codes, RT‐PCR, or viral culture
  Gulf/Middle East                                                                                                                                                                                                                                                                                                                                                        
  Rowlinson et al., 2013[34](#ppul23570-bib-0034){ref-type="ref"}            Egypt            April 1, 2009--March 31, 2012 (hospital); May 1, 2011--April 30, 2012 (outpatient)   Hospitalized or outpatient children with respiratory illness                                                                       5,852                         Passive               RT‐PCR
  El Kholy et al., 2013[47](#ppul23570-bib-0047){ref-type="ref"}             Egypt            February 2010--May 2011                                                              Hospitalized children with severe ARI                                                                                              240                           Passive               RT‐PCR
  Khuri‐Bulos et al., 2010[50](#ppul23570-bib-0050){ref-type="ref"}          Jordan           January 2007--March 2007                                                             Children \<5 years old admitted with ARI and/or fever                                                                              743                           Active and passive    RT‐PCR
  Al‐Muhsen et al., 2010[42](#ppul23570-bib-0042){ref-type="ref"}            Saudi Arabia     January 2003--January 2009                                                           Children \<6 months old with RSV‐associated bronchiolitis admitted to the PICU                                                     70                            Passive               DFA
  Hacimustafaoglu et al., 2013[21](#ppul23570-bib-0021){ref-type="ref"}      Turkey           March 2010--February 2011 (hospitalized)                                             Children ≤2 years old admitted for ARI                                                                                             671                           Passive               Immunochromatographic assay
  Latin America                                                                                                                                                                                                                                                                                                                                                           
  Ferolla et al., 2013[19](#ppul23570-bib-0019){ref-type="ref"}              Argentina        2011                                                                                 Children \<2 years old with severe ARI and oxygen saturation \<93%                                                                 2,587                         Passive               RT‐PCR
  Arruda et al., 2014[10](#ppul23570-bib-0010){ref-type="ref"}               Brazil           January 2008--December 2010                                                          Infants ≤35 weeks gestational age, followed for 1 year                                                                             310                           Active and passive    RT‐PCR
  Oliveira et al., 2008[54](#ppul23570-bib-0054){ref-type="ref"}             Brazil           2000--2007                                                                           Children \<5 years old with acute respiratory distress                                                                             475                           Active and passive    DFA, RT‐PCR
  Pecchini et al., 2008[55](#ppul23570-bib-0055){ref-type="ref"}             Brazil           February 2005--September 2006                                                        Children \<5 years old admitted with ARI                                                                                           455                           Passive               IFA
  Riccetto et al., 2006[57](#ppul23570-bib-0057){ref-type="ref"}             Brazil           April 2004--September 2004                                                           Infants 0--12 months old admitted with ARI                                                                                         152                           Passive               DFA
  Avendano et al., 2003[11](#ppul23570-bib-0011){ref-type="ref"}             Chile            January 1989--December 2000                                                          Children \<2 years old admitted with ARI                                                                                           4,618                         Passive               IFA
  Pineros et al., 2013[56](#ppul23570-bib-0056){ref-type="ref"}              Colombia         April 2005--April 2006                                                               Infants \<1 year old presenting to the ED with respiratory symptoms                                                                717                           Passive               Rapid IF
  McCracken et al., 2013[24](#ppul23570-bib-0024){ref-type="ref"}            Guatemala        November 2007--April 2012                                                            Hospital or clinic patients with ARI                                                                                               6,626                         Active                RT‐PCR
  Noyola et al., 2006[53](#ppul23570-bib-0053){ref-type="ref"}               Mexico           May 2003--April 2005                                                                 Hospitalized patients \<3 years old with ARI                                                                                       2,036                         Passive               DFA
  Ochoa et al., 2014[30](#ppul23570-bib-0030){ref-type="ref"}                Peru             March 2009--March 2010                                                               Infants with a birth weight \<1500 g and gestational age ≤37 weeks, followed for 1 year                                            222                           Passive and active    IFA

ARI, acute respiratory infection; DFA, direct fluorescent antibody; ED, emergency department; EIA, enzyme immunoassay; ELISA, enzyme‐linked immunosorbent assay; ICD‐9‐CM diagnosis codes: 079.6 (RSV infection), 480.1 (RSV pneumonia), 466.11 (RSV bronchiolitis), 466.19 (bronchiolitis, other); IF, immunofluorescence; IFA, indirect immunofluorescent assay; NICU, neonatal intensive care unit; NR, not reported; PICU, pediatric intensive care unit; RSV, respiratory syncytial virus; RT‐PCR, (real‐time) reverse transcriptase polymerase chain reaction; WHO, World Health Organization.

© 2016 Wiley Periodicals, Inc.

Six studies reported incidence rates of RSV‐associated ARI hospitalization among children \<6 months of age. The global incidence estimate, inclusive of all studies (n = 6), was 20.01 (95 % CrI, 9.65--41.31). The study‐level incidence estimates ranged from 9.50 (95% CrI, 8.61--10.48) for Guatemala to as high as 41.90 (95%CrI, 32.69--53.71) for the United States.

Eighteen studies provided incidence rates of RSV‐associated ARI hospitalization among children \<1 year of age. The global incidence estimate was 19.19 (95% CrI, 15.04--24.48). The study‐level incidence estimates ranged from 7.85 (95% CrI, 5.55--11.10) for India to 50.69 (95% CrI, 28.07--91.54) for Denmark. In this age group, there was sufficient data to perform regional estimates of incidence for Asia and Australia/Europe/United States (i.e., greater than four study‐level estimates within each region). Interestingly, the incidence was approximately 1.4 times greater in Australia/Europe/United States (23.69; 95% CrI, 15.08--39.98) compared with Asia (16.40; 95% CrI, 7.79--34.08).

Fifteen studies provided incidence rates of RSV‐associated ARI hospitalization among children \<5 years of age. The global incidence estimate was 4.37 (95% CrI, 2.98--6.42), with study‐level incidence estimates ranging from 1.40 (95% CrI, 0.97--2.03) for Mozambique to 11.20 (95% CrI, 10.61--11.82) for South Africa. The regional incidence estimates were similar for Africa (4.57; 95% CrI, 1.25--16.19) and Asia (4.95; 95% CrI, 2.69--8.95).

Six studies focused specifically on the incidence of RSV‐associated ARI hospitalization among preterm children \<1 year of age and resulted in a global estimate of 63.85 (95% CrI, 37.52--109.7). The incidence estimates at the study level ranged from 39.42 (95% CrI, 28.69--54.17) for the Netherlands to 116.20 (95% Crl 83.81, 161.10) for Peru.

Death Among the Children With Severe RSV‐ARI, Measured as Case Fatality {#ppul23570-sec-0008}
-----------------------------------------------------------------------

Thirty‐seven studies[10](#ppul23570-bib-0010){ref-type="ref"}, [14](#ppul23570-bib-0014){ref-type="ref"}, [17](#ppul23570-bib-0017){ref-type="ref"}, [19](#ppul23570-bib-0019){ref-type="ref"}, [20](#ppul23570-bib-0020){ref-type="ref"}, [22](#ppul23570-bib-0022){ref-type="ref"}, [24](#ppul23570-bib-0024){ref-type="ref"}, [25](#ppul23570-bib-0025){ref-type="ref"}, [26](#ppul23570-bib-0026){ref-type="ref"}, [27](#ppul23570-bib-0027){ref-type="ref"}, [28](#ppul23570-bib-0028){ref-type="ref"}, [29](#ppul23570-bib-0029){ref-type="ref"}, [30](#ppul23570-bib-0030){ref-type="ref"}, [31](#ppul23570-bib-0031){ref-type="ref"}, [32](#ppul23570-bib-0032){ref-type="ref"}, [34](#ppul23570-bib-0034){ref-type="ref"}, [37](#ppul23570-bib-0037){ref-type="ref"}, [42](#ppul23570-bib-0042){ref-type="ref"}, [43](#ppul23570-bib-0043){ref-type="ref"}, [44](#ppul23570-bib-0044){ref-type="ref"}, [45](#ppul23570-bib-0045){ref-type="ref"}, [46](#ppul23570-bib-0046){ref-type="ref"}, [47](#ppul23570-bib-0047){ref-type="ref"}, [48](#ppul23570-bib-0048){ref-type="ref"}, [49](#ppul23570-bib-0049){ref-type="ref"}, [50](#ppul23570-bib-0050){ref-type="ref"}, [51](#ppul23570-bib-0051){ref-type="ref"}, [52](#ppul23570-bib-0052){ref-type="ref"}, [53](#ppul23570-bib-0053){ref-type="ref"}, [54](#ppul23570-bib-0054){ref-type="ref"}, [55](#ppul23570-bib-0055){ref-type="ref"}, [56](#ppul23570-bib-0056){ref-type="ref"}, [57](#ppul23570-bib-0057){ref-type="ref"}, [58](#ppul23570-bib-0058){ref-type="ref"}, [59](#ppul23570-bib-0059){ref-type="ref"}, [60](#ppul23570-bib-0060){ref-type="ref"}, [61](#ppul23570-bib-0061){ref-type="ref"}, [62](#ppul23570-bib-0062){ref-type="ref"} from 24 countries published between 2002 and 2014, with suitable case fatality data among children \<5 years of age with community‐acquired, medically attended, confirmed RSV‐ARI were included in the mortality analysis. The case fatality estimates (reported per 1,000 children) were stratified according to age and region (Table [3](#ppul23570-tbl-0003){ref-type="table-wrap"}). The case fatality estimates for each age group at the regional level were constructed from separate estimates at the study level, when four or more study estimates were available. Global case fatality estimates for each age group were constructed from all of the estimates at the study level.

###### 

Case Fatality for Children \<6 Months to 5 Years of Age (Per 1,000 Children)

  Age                                                                                            Study                                                                                         Case fatality per 1,000 children (n/N)   Meta‐analysis of case fatality (95% CrI)
  ---------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------- ---------------------------------------- ------------------------------------------
  Africa                                                                                                                                                                                                                                
  \<6 months                                                                                                                                                                                                                            
  \<1 year                                                                                       Kenya[28](#ppul23570-bib-0028){ref-type="ref"}                                                21.5 (15/697)                            n/a
  \<1 year preterm                                                                                                                                                                                                                      
  \<2 years                                                                                      South Africa[52](#ppul23570-bib-0052){ref-type="ref"}                                         0 (0/25)                                 n/a
  2--5 years                                                                                                                                                                                                                            
  \<5 years                                                                                      Kenya[28](#ppul23570-bib-0028){ref-type="ref"}                                                23.8 (21/884)                            18.45 (6.13--56.13)
  Morocco[49](#ppul23570-bib-0049){ref-type="ref"}                                               32 (4/125)                                                                                                                             
  Mozambique[29](#ppul23570-bib-0029){ref-type="ref"}                                            71.4 (2/28)                                                                                                                            
  South Africa[46](#ppul23570-bib-0046){ref-type="ref"}                                          6.4 (14/2204)                                                                                                                          
  South Africa[25](#ppul23570-bib-0025){ref-type="ref"}                                          4 (3/751)                                                                                                                              
  South Africa[60](#ppul23570-bib-0060){ref-type="ref"}                                          61.5 (8/130)                                                                                                                           
  Asia                                                                                                                                                                                                                                  
  \<6 months                                                                                     China[61](#ppul23570-bib-0061){ref-type="ref"}                                                0 (0/39)                                 n/a
  South Korea[45](#ppul23570-bib-0045){ref-type="ref"}                                           0 (0/46)                                                                                                                               
  \<1 year                                                                                       China[51](#ppul23570-bib-0051){ref-type="ref"}                                                30.8 (2/65)                              8.43 (1.79--23.88)
  China[62](#ppul23570-bib-0062){ref-type="ref"}                                                 9.9 (9/913)                                                                                                                            
  Taiwan[44](#ppul23570-bib-0044){ref-type="ref"}                                                0 (0/83)                                                                                                                               
  Thailand[20](#ppul23570-bib-0020){ref-type="ref"}                                              0 (0/148)                                                                                                                              
  Thailand[59](#ppul23570-bib-0059){ref-type="ref"}                                              19.2 (2/104)                                                                                                                           
  \<1 year preterm                                                                               Korea[32](#ppul23570-bib-0032){ref-type="ref"}, [^\*^](#ppul23570-note-0009){ref-type="fn"}   0 (0/37)                                 n/a
  \<2 years                                                                                      China[61](#ppul23570-bib-0061){ref-type="ref"}                                                0 (0/47)                                 12.12 (1.61--45.17)
  India[48](#ppul23570-bib-0048){ref-type="ref"}                                                 53.6 (3/56)                                                                                                                            
  Indonesia[17](#ppul23570-bib-0017){ref-type="ref"}                                             19.2 (12/625)                                                                                                                          
  Taiwan[44](#ppul23570-bib-0044){ref-type="ref"}                                                0 (0/121)                                                                                                                              
  2--5 years                                                                                     Taiwan[44](#ppul23570-bib-0044){ref-type="ref"}                                               0 (0/32)                                 n/a
  \<5 years                                                                                      Bangladesh[27](#ppul23570-bib-0027){ref-type="ref"}                                           0 (0/22)                                 1.11 (0.25--3.05)
  Taiwan[44](#ppul23570-bib-0044){ref-type="ref"}                                                0 (0/153)                                                                                                                              
  Taiwan[14](#ppul23570-bib-0014){ref-type="ref"}                                                1.2 (13/11,081)                                                                                                                        
  Thailand[20](#ppul23570-bib-0020){ref-type="ref"}                                              2.4 (1/425)                                                                                                                            
  Thailand[26](#ppul23570-bib-0026){ref-type="ref"}                                              1.2 (1/802)                                                                                                                            
  Thailand[37](#ppul23570-bib-0037){ref-type="ref"}                                              0 (0/45)                                                                                                                               
  Australia, Europe, United States                                                                                                                                                                                                      
  \<6 months                                                                                     Switzerland[58](#ppul23570-bib-0058){ref-type="ref"}                                          0 (0/130)                                n/a
  \<1 year                                                                                                                                                                                                                              
  \<1 year preterm                                                                                                                                                                                                                      
  \<2 years                                                                                      United States[43](#ppul23570-bib-0043){ref-type="ref"}                                        0.9 (121/141,245)                        n/a
  2--5 years                                                                                                                                                                                                                            
  \<5 years                                                                                      United States[31](#ppul23570-bib-0031){ref-type="ref"}                                        1.3 (23/17,539)                          n/a
  Latin America                                                                                                                                                                                                                         
  \<6 months                                                                                     Mexico[53](#ppul23570-bib-0053){ref-type="ref"}                                               0 (0/81)                                 n/a
  \<1 year                                                                                       Brazil[57](#ppul23570-bib-0057){ref-type="ref"}                                               0 (0/26)                                 n/a
  Mexico[53](#ppul23570-bib-0053){ref-type="ref"}                                                0 (0/121)                                                                                                                              
  \<1 year preterm                                                                               Brazil[10](#ppul23570-bib-0010){ref-type="ref"}, [^†^](#ppul23570-note-0010){ref-type="fn"}   33.3 (1/30)                              n/a
  Brazil[57](#ppul23570-bib-0057){ref-type="ref"}, [^\*^](#ppul23570-note-0009){ref-type="fn"}   0 (0/7)                                                                                                                                
  Peru[30](#ppul23570-bib-0030){ref-type="ref"}, [^‡^](#ppul23570-note-0011){ref-type="fn"}      27.8 (1/36)                                                                                                                            
  \<2 years                                                                                      Argentina[19](#ppul23570-bib-0019){ref-type="ref"}                                            11.3 (9/797)                             n/a
  Colombia[56](#ppul23570-bib-0056){ref-type="ref"}                                              9.3 (2/216)                                                                                                                            
  Mexico[53](#ppul23570-bib-0053){ref-type="ref"}                                                0 (0/144)                                                                                                                              
  2--5 years                                                                                                                                                                                                                            
  \<5 years                                                                                      Brazil[54](#ppul23570-bib-0054){ref-type="ref"}                                               50 (1/20)                                n/a
  Brazil[55](#ppul23570-bib-0055){ref-type="ref"}                                                21.7 (2/92)                                                                                                                            
  Guatemala[24](#ppul23570-bib-0024){ref-type="ref"}                                             25.1 (34/1353)                                                                                                                         
  Gulf/Middle East                                                                                                                                                                                                                      
  \<6 months                                                                                                                                                                                                                            
  \<1 year                                                                                       Egypt[47](#ppul23570-bib-0047){ref-type="ref"}                                                53.9 (11/204)                            n/a
  Egypt[34](#ppul23570-bib-0034){ref-type="ref"}                                                 0 (0/350)                                                                                                                              
  Saudi Arabia[42](#ppul23570-bib-0042){ref-type="ref"}                                          14.3 (1/70)                                                                                                                            
  \<1 year preterm                                                                                                                                                                                                                      
  \<2 years                                                                                                                                                                                                                             
  2--5 years                                                                                                                                                                                                                            
  \<5 years                                                                                      Jordan[50](#ppul23570-bib-0050){ref-type="ref"}                                               8.6 (4/467)                              n/a
  Egypt[34](#ppul23570-bib-0034){ref-type="ref"}                                                 0 (0/467)                                                                                                                              
  Global                                                                                                                                                                                                                                
  \<6 months                                                                                                                                                                                                                            n/a
  \<1 year                                                                                                                                                                                                                              6.60 (1.85--16.93)
  \<1 years preterm                                                                                                                                                                                                                     1.04 (0.17--12.06)
  2 years                                                                                                                                                                                                                               4.68 (1.23--14.70)
  \<2--5 years                                                                                                                                                                                                                          n/a
  \<5 year                                                                                                                                                                                                                              6.21 (2.64--13.73)

CrI, credible interval; n, number of deaths; N, number of children included in analysis; n/a, not analyzed.

Gestational age: \<35 weeks.

Gestational age: \<36 weeks.

Gestational age: \<37 weeks.

© 2016 Wiley Periodicals, Inc.

Twelve studies provided case fatality data among children \<1 year of age with severe RSV‐ARI. The estimated global case fatality, inclusive of all studies (n = 12), was 6.60 (95% CrI, 1.85--16.93). The study‐level incidence estimates ranged from 0 in Taiwan, Thailand, Switzerland, Brazil, and Mexico, to 53.9 (11/204) in Egypt. In this age group, there were sufficient data to perform regional estimates of case fatality for Asia, which was 8.43 (95% CrI, 1.79--23.88).

Four studies from Brazil, Korea, and Peru focused specifically on case fatality among preterm children \<1 year of age with severe RSV‐ARI. The estimated global case fatality, inclusive of all studies (n = 4), was 1.04 (95% CrI, 0.17--12.06). Two studies were conducted in Brazil and resulted in different case fatality estimates, 0 and 33.3. The case fatality estimates for Korea and Peru were 0 and 27.8, respectively.

Eighteen studies provided case fatality data among children \<5 years of age with severe RSV‐ARI. The estimated global case fatality, inclusive of all studies (n = 18), was 6.21 (95% CrI, 2.64--13.73), with the highest rates reported from studies in Africa, including Kenya, Morocco, Mozambique, and South Africa.

DISCUSSION {#ppul23570-sec-0009}
==========

Our analysis of 34 studies from 26 countries, representing data on the incidence of hospitalization for community‐acquired, medically attended, severe RSV‐ARI, demonstrates that a substantial proportion of RSV‐associated morbidity occurs in the first year of life, especially in children with a history of prematurity. The global incidence of RSV‐associated ARI hospitalization among preterm infants (63.85; 95% CrI, 37.52--109.7) was 3 times greater than was reported for term children \<1 year of age (19.19; 95% CrI, 15.04--24.48). This is consistent with published data reporting earlier gestational age and younger chronological age to be associated with severe RSV disease and risk of RSV hospitalization.

The global incidence estimate of RSV‐associated ARI hospitalization among children \<6 months (20.01; 95 % CrI, 9.65--41.31) was similar compared with children \<1 year of age (19.19; 95% CrI, 15.04--24.48). This finding is consistent with the results published by Nair et al.[3](#ppul23570-bib-0003){ref-type="ref"} They estimated the incidence of RSV‐associated severe ALRI necessitating hospital admission among children \<1 year of age in developing countries to be 17.9 (95% CI, 14.5--22.2) and 19 (95% CI, 14.6--24.8) in industrialized countries. Interestingly, we observed the incidence in children \<1 year of age was approximately 1.4 times greater in Australia/Europe/United States (23.69; 95% CrI, 15.08--39.98) compared with Asia (16.40; 95% CrI, 7.79--34.08). This perhaps can be explained by differences in case ascertainment, greater access to care, and broader sampling in hospital settings in the former region.[63](#ppul23570-bib-0063){ref-type="ref"}

As expected, the global incidence estimate of RSV‐associated ARI hospitalization among children \<5 years of age (4.37; 95% CrI, 2.98--6.42) was lower compared with children \<1 year of age (19.19; 95% CrI, 15.04--24.48). Similar to the results observed from children \<1 year of age, our global estimate for children \<5 years of age was consistent with the findings by Nair et al,[3](#ppul23570-bib-0003){ref-type="ref"} where the reported incidence for RSV‐associated severe ALRI for children \<5 years of age was 5.6 (95% CI, 4.3--7.4) for developing countries and 5.5 (95% CI, 4.2--7.2) for industrialized countries.

The global incidence estimates of RSV‐ARI hospitalization among premature children \<1 year of age were nearly 3 times greater than in children \<1 year of age and 16 times higher than that of children \<5 years of age with no history of prematurity, 63.85 (95% CrI, 37.52--109.7) versus 19.19 (95% CrI, 15.04--24.48) versus 4.37 (95% CrI, 2.98--6.42), respectively. These data clearly demonstrate the important role of RSV in the causation of hospitalization in premature children and gestational age as a critical determinant of disease severity.

Cause‐specific mortality is an essential metric of population health intelligence and is vital to inform health care prioritization to target interventions to maximize population health. After malaria, RSV is the dominant pathogen‐specific cause of post‐neonatal death in the first year of life among infants worldwide.[64](#ppul23570-bib-0064){ref-type="ref"} Our analysis from 37 studies from 24 countries, published between 2002 and 2014, affirms the importance of RSV disease as a significant contributor to pediatric mortality.

The estimated global case fatality was lower among preterm children with severe RSV‐ARI compared with term children; 1.04 (95% CrI, 0.17--12.06) episodes per 1,000 children at risk versus 6.60 (95% Crl, 1.85--16.93), respectively. However, as only four studies were included in the analysis among preterm children, the paucity of mortality information in this population precludes any conclusions. In addition, 3 of the studies were conducted in developing countries which may introduce bias toward misleadingly low estimates. Further many ALRTI deaths in children in lower middle income countries (LMICs) occur outside a health facility, but published case fatality rates predominantly report in‐hospital deaths. Further data regarding childhood mortality in community settings is needed.

The estimated global case fatality for children \<5 years of age with severe RSV‐ARI was similar to the case fatality estimates in a previous report[3](#ppul23570-bib-0003){ref-type="ref"} where Nair et al. estimated the RSV‐associated ALRI case fatality ratio (CFR) to be 0.3 and 2.1 per 100 children \<5 years of age in industrialized and developing countries, respectively.

Our findings should be interpreted cautiously as there are several limitations to this study. Incidence of RSV‐associated ARI hospitalization and case fatality estimates among children with severe RSV‐ARI are uncertain and can be greatly overestimated or underestimated due to a variety of reasons. Methodological differences such as case ascertainment, and differences among the diagnostic assays used to identify RSV infection may affect estimates. In addition, estimates can be affected by surveillance bias due to disparity in access to hospital care and resources across countries. Finally, in developing countries where the vast majority of deaths due to RSV occur, a high percentage of deaths occur outside of the hospital setting and are not routinely captured or recorded.[19](#ppul23570-bib-0019){ref-type="ref"} An important limitation regarding the case‐fatality estimates was the absence of individual patient characteristics of non‐surviving patients. Consequently, the role of comorbidity, and coinfections in RSV‐related deaths could not be evaluated. Moreover, case‐fatality ratios cannot be translated to population‐based mortality. In addition, our study did not examine the influence of other socio‐demographic risk factors for RSV‐associated ARI hospitalization or case fatality beyond prematurity. Among them, low birth weight, being male, maternal smoking, siblings, history of atopy, no breastfeeding and crowding (\>7 persons in the household), have been observed to be significantly associated with RSV‐associated ALRI.[65](#ppul23570-bib-0065){ref-type="ref"} Our search excluded non‐English language studies. Other limitations include large variability in countries represented in each age group category; therefore any inference from comparing age groups should also be interpreted with caution and some studies had small sample sizes, which led to variability in meta‐analytic estimates. Finally, there are minimal published data for several countries with large, high‐burden populations, such as specific areas in Latin America and Africa. There are no data for the incidence of RSV‐associated ARI hospitalizations or case fatality among Canadian First Nation and Inuit children meeting the inclusion criteria for this systematic review. Notably, Inuit children living in the Baffin (Qikiqtani) Region, Nunavut, have the highest known rates of RSV bronchiolitis requiring hospitalization, with rates up to 484 per 1,000 infants \<6 months of age,[66](#ppul23570-bib-0066){ref-type="ref"} versus 27 per 1,000 infants in temperate Canada and the United States.[22](#ppul23570-bib-0022){ref-type="ref"} Also, Inuit children often experience repeated, severe RSV infections in the same season, which is unusual elsewhere.[67](#ppul23570-bib-0067){ref-type="ref"}

A unique aspect and strength of this review include the use of technology‐assisted search and screening. Doctor Evidence utilizes a proprietary software platform for literature searching and screening called DOC™ Library, a web‐based, centralized literature search and repository tool that retrieves, stores, and categorizes literature. The DOC™ Library software technology supports and enhances the work of experienced librarians to maximize retrieval of relevant studies and to minimize return of irrelevant results through pattern recognition, keyword recognition, correction and/or re‐categorization of studies due to inaccuracies found in subject heading descriptor (e.g., MeSH/Emtree) and Pubmed/Embase filters, automated creation of an accurate PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) diagram, and machine learning/natural language processing. This technology helps to provide a more comprehensive and relevant set of results than typical literature searching yields.

CONCLUSIONS {#ppul23570-sec-0010}
===========

Using a different search methodology, these data are remarkably similar to the findings by Nair et al.[3](#ppul23570-bib-0003){ref-type="ref"} and affirm the importance of RSV disease in the causation of hospitalization and as a significant contributor to pediatric mortality. A unique contribution from our study is the systematic review and meta‐analysis specific to premature children, which further demonstrate gestational age as a critical determinant of disease severity. A gap in mortality data is the absence of individual patient characteristics and, consequently, the role of comorbidity in RSV‐related deaths cannot be excluded. Given the burden of RSV worldwide, and until an effective RSV vaccine is globally available, more research is urgently needed to improve prevention and care across different populations and resource settings to reduce childhood morbidity and mortality associated with this disease.
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